After reading the title of the article, it is difficult to know whether article is about finding Rosiglitazone and Metformin in patients (may be in their pockets?) or treating patients with these drugs. Authors should have spent more time in selecting the title of their article. In a disease such as Diabetes Mellitus type 2, where there is progressive worsening of the disease, not having a control group severely limits the utility of the study. As I have access to abstract only, I will limit my comments to these two points. I assume other deficiences in the abstract are addressed in the manuscript of the article.
Posted by: rqayyum - Aug 2005